The influence of generator eluate on the radiochemical purity of 99Tcm-sestamibi prepared using fractionated Cardiolite kits. 1998

P Varelis, and S L Parkes, and M T Poot
Department of Nuclear Medicine, St George Hospital, Kogarah, NSW, Australia.

The reconstitution of fractionated Cardiolite kits with sodium 99Tcm-pertechnetate eluted from a wet-column 99Mo/99Tcm generator results in a preparation that contains elevated amounts of a polar radiochemical impurity, which is normally present in only trace amounts when such kits are reconstituted with eluate from a dry-column generator. A consequence of this impurity, which appears to be an organotechnetium compound, is that it causes a positive bias in several quality control methods for 99Tcm-sestamibi, including that recommended by the manufacturer. This impurity was isolated, and its biodistribution determined in Wistar rats. Two alternative methods for the preparation of 99Tcm-sestamibi from fractionated Cardiolite kits using eluate from a wet-column generator were investigated. A rapid procedure, based on a C18 solid phase extraction (SPE) cartridge, for measuring the radiochemical purity of 99Tcm-sestamibi samples, which had been prepared using fractionated Cardiolite kits, was developed and compared with two other methods including high-performance liquid chromatography (HPLC). Over a radiochemical purity range of 49-98%, the values obtained using our quality control method deviated from those obtained using HPLC by 1.1 +/- 1.3% (n = 26). In contrast to some of the rapid quality control methods assessed in our investigation, the SPE technique was not biased by the presence of the organotechnetium impurity.

UI MeSH Term Description Entries
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002854 Chromatography, Paper An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper (stationary phase) by their varied degree of solubility/mobility in the eluting solvent (mobile phase). Paper Chromatography,Chromatographies, Paper,Paper Chromatographies
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D017256 Technetium Tc 99m Sestamibi A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack. 99mTc-Hexamibi,99mTc-Sestamibi,Tc MIBI,Cardiolite,Tc-99m-Methoxy-2-isobutylisonitrile,Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile,Technetium Tc 99m Sestamibi Chloride,Technetium-99m-Hexamibi,Technetium-99m-Sestamibi,99mTc Hexamibi,99mTc Sestamibi,Tc 99m Methoxy 2 isobutylisonitrile,Technetium 99m Hexamibi,Technetium 99m Sestamibi,Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

P Varelis, and S L Parkes, and M T Poot
March 1995, Nuclear medicine communications,
P Varelis, and S L Parkes, and M T Poot
September 2012, Journal of nuclear medicine technology,
P Varelis, and S L Parkes, and M T Poot
February 1995, Nuclear medicine communications,
P Varelis, and S L Parkes, and M T Poot
April 2000, Nuclear medicine communications,
P Varelis, and S L Parkes, and M T Poot
October 1995, Nuclear medicine and biology,
P Varelis, and S L Parkes, and M T Poot
May 1981, The International journal of applied radiation and isotopes,
P Varelis, and S L Parkes, and M T Poot
January 2000, Nuclear medicine communications,
P Varelis, and S L Parkes, and M T Poot
August 1999, Nuclear medicine communications,
P Varelis, and S L Parkes, and M T Poot
March 2005, Journal of nuclear medicine technology,
P Varelis, and S L Parkes, and M T Poot
February 1994, Nuklearmedizin. Nuclear medicine,
Copied contents to your clipboard!